T-cell responses to autoantigens in IDDM: The search for the holy grail

Diabetes

Volumn 45, Issue 9, 1996, Pages 1147-1156

  Roep, Bart O ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; HEAT SHOCK PROTEIN; INSULIN;

ANTIGEN RECOGNITION; HLA TYPING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TARGET CELL;

EID: 0029837397     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.9.1147     Document Type: Review

References (123)

1. Eisenbarth GS: Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 314:1360-1368, 1986
2. Harrison LC, Campbell IL, Colman PG, Chosich N, Kay THW, Tait BD, Bartholomeusz RK, De Aizpurua HJ, Joseph JL, Chu S, Kielczynski WE: Type I diabetes: immunopathology and immunotherapy. Adv Endocrinol Metab 1:36-94, 1990
3. Gepts W: Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-663, 1965
4. Roep BO, De Vries RRP: T-lymphocytes and the pathogenesis of type-I (insulin-dependent) diabetes-mellitus (Review). Eur J Clin Invest 22: 697-711, 1992
5. Huang X, Yuan J, Goddard A, Foulis A, James RFL, Lernmark A, Pujol-Borrell R, Rabinovitch A, Somoza N, Stewart TA: Interferon expression in the pancreas of patients with type 1 diabetes. Diabetes 44:658-664, 1995
6. Stiller CR, Dupre J, Gent M, Jenner MR, Keown PA, Laupacis A, Martell R, Rodger NW, von Graffenfried B, Wolfe BMJ: Effects of cyclosporin immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 223:1362-1367, 1984
7. Bougneres PF, Carel JC, Castano L, Boitard C, Gardin JP, Landais P, Hors J, Mihatsch MJ, Paillard M, Chaussain JL, Bach JF: Factors associated with early remission of type I diabetes in children treated with cyclosporine. N Engl J Med 318:663-670, 1988
8. Sibley R, Sutherland DER, Goetz F, Michael AF: Recurrent diabetes mellitus in the pancreas iso- and allograft: a light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53:132-144, 1985
9. Lampeter EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J, Grossewilde H, Gries FA, Kolb H: Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341:1243-1244, 1993
10. Wicker LS, Miller BJ, Mullen Y: Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35:855-860, 1986
11. Bendelac A, Carnaud C, Boitard C, Bach JF: Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates: requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med 166:823-832, 1987
12. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR: In situ characterization of autoimmune phenomena and expression of HLA class II molecules in the pancreas in diabetic insulitis. N Engl J Med 313:353-360, 1985
13. Foulis AK, McGill M, Farquharson MA: Insulitis in type-1 (insulin-dependent) diabetes-mellitus in man: macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol 165:97-103, 1991
14. Hänninen A, Jalkanen S, Salmi M, Toikkanen S, Nikolakaros G, Simell O: Macrophages, T-cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes-mellitus. J Clin Invest 90:1901-1910, 1992
15. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriquezrilo H, Finegold D, Trucco M: Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371:351-355, 1994
16. Somoza N, Vargas F, Rouramir C, Vivespi M, Fernandezfigueras MT, Ariza A, Gomis R, Bragado R, Marti M, Jaraquemada D, Pujol-Borrell R: Pancreas in recent onset insulin-dependent diabetes mellitus: changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol 153:1360-1377, 1994
17. Kontiainen S, James RL, Feldmann M: Human islet cell induced T cell lines and clones from diabetic children. Autoimmunity 8:193-197, 1991
18. Harrison LC, De Aizpurua H, Loudovaris T, Campbell IL, Cebon JS, Tait BD, Colman PG: Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes 40:1128-1133, 1991
19. Peakman M, Wen L, McNab GL, Watkins PJ, Tan KC, Vergani D: T cell clones generated from patients with type 1 diabetes using interleukin-2 proliferate to human islet antigens. Autoimmunity 17:31-39, 1994
20. Roep BO, Kallan AA, Duinkerken G, Arden SD, Hutton JC, Bruining GJ, De Vries RRP: T-cell reactivity to β-cell membrane antigens associated with β-cell destruction in IDDM. Diabetes 44:278-283, 1995
21. Chang JCC, Linarelli LG, Laxer JA, Froning KJ, Caralli LL, Brostoff SW, Carlo DJ: Insulin-secretory-granule specific T-cell clones in human IDDM. J Autoimmun 8:221-224, 1995
22. MacCuish AC, Jordan J, Campbell CJ, Duncan LPJ, Irvine WJ: Cell mediated immunity in diabetes mellitus: lymphocyte transformation by insulin and insulin fragments in insulin treated and newly diagnosed diabetics. Diabetes 24:36-43, 1975
23. Naquet P, Ellis J, Tibensky D, Kenshole A, Singh B, Hodges R, Delovitch TL: T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J Immunol 140:2569-2578, 1988
24. Roep BO, Arden SD, De Vries RRP, Hutton JC: T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 345:632-634, 1990
25. Roep BO, Kallan AA, Hazenbos WL, Bruining GJ, Bailyes EM, Arden SD, Hutton JC, De Vries RRP: T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet 337:1439-1441, 1991
26. Atkinson MA, Kaufman DL. Campbell L, Gibbs KA, Shah SC, Bu DF, Erlander MG, Tobin AJ, Maclaren NK: Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339:458-459, 1992
27. Honeyman MC, Cram DS, Harrison LC: Gltitamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. J Exp Med 177:535-540, 1993
28. Kallan AA, Roep BO, Arden SD, Hutton JC, De Vries RRP: Beta-cell reactive T-cell clones from type 1 diabetes patients are not beta cell specific and recognize multiple antigens. J Autoimmun 8:887-899, 1995
29. Lohmann T, Leslie RDG, Hawa M, Geysen M, Rodda S, Londei M: Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 343:1607-1608, 1994
30. Petersen JS, Russel S, Marshall MO, Kofod H, Buschard K, Cambon N, Karlsen AE, Boel E, Hagopian WA, Hejnaes KR, Moody A, Dyrberg T, Lernmark A, Marlsen OD, Michelsen BK: Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 42:484-495, 1993
31. Kim J, Richter W, Aanstoot HJ, Shi YG, Fu Q, Rajotte R, Warnock G, Baekkeskov S: Differential expression of GAD(65) and GAD(67) in human, rat, and mouse pancreatic islets. Diabetes 42:1799-1808, 1993
32. Santamaria P, Nakhleh RE, Sutherland DE, Barbosa JJ. Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes 41:53-61, 1992
33. Santamaria P, Lewis C, Jessurun J, Sutherland DER, Barbosa JJ: Skewed T-cell receptor usage and junctional heterogeneity among isletitis αβ and γδ T-cells in human IDDM. Diabetes 43:599-606, 1994
34. Kontiainen S, Toomath R, Lowder J, Feldmann M: Selective activation of T cells in newly diagnosed insulin-dependent diabetic patients: evidence for heterogeneity of T cell receptor usage. Clin Exp Immunol 83:347-351, 1991
35. Durinovic-Bellò I, Steinle A, Ziegler AG, Schendel DJ: HLA-DQ-restricted, islet-specific T-cell clones of a type I diabetic patient: T-cell receptor sequence similarities to insulitis-inducing T-cells of nonobese diabetic mice. Diabetes 43:1318-1325, 1994
36. Sorger SB, Matis LA, Engel I, McElligott DL, Fink PJ, Hedrick SM: The influence of MHC gene products on the generation of an antigen-specific T-cell repertoire. Ann NY Acad Sci 532:18-32, 1988
37. Lampeter EF, Seifert I, Lohmann D, Heise JW, Bertrams J, Christie MR, Kolb-Bachofen V, Kolb H: Inflammatory islet damage in patients bearing HLA-Dr 3 and/or Dr 4 haplotypes does not lead to islet autoimmunity. Diabetologia 37:471-475, 1994
38. Bierwolf B, Verlohren HJ, Lohmann D, Lampeter EF, Krug J: A follow-up study of cell-mediated cytotoxicity and beta cell function in type I diabetes. Exp Clin Endocrinol 89:363-367, 1987
39. Roep BO, Kallan AA, De Vries RRP: β-cell antigen specific lysis of macrophages by CD4 T-cell clones from newly diagnosed IDDM patient: a putative mechanism of T-cell mediated autoimmune islet cell destruction. Diabetes 41:1380-1384, 1992
40. Panina-Bordignon P, Lang R, van Endert PM, Benazzi E, Felix AM, Pastore RM, Spinas GA, Sinigaglia F: Cytotoxic T-cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 181:1923-1927, 1995
41. Ilonen J, Surcel HM, Kaar ML: Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes. Clin Exp Immunol 80:278-281, 1991
42. Buschard K, Ropke C, Madsbad S, Mehlsen J, Rygaard J: T lymphocyte subsets in patients with newly diagnosed type 1 (insulin-dependent) diabetes: a prospective study. Diabetologia 25:247-251, 1983
43. al-Sakkaf L, Pozzilli P, Tarn AC, Schwarz G, Gale EA, Bottazzo GF: Persistent reduction of CD4/CD8 lymphocyte ratio and cell activation before the onset of type 1 (insulin-dependent) diabetes. Diabetologia 32:322-325, 1989
44. Faustman DL: Occult CD45 T cell developmental defect in type 1 diabetes. Diabete Metab 19:446-457, 1993
45. Smerdon RA, Peakman M, Hussain MJ, Alviggi L, Watkins PJ, Leslie DG, Vergani D: Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes 42:127-133, 1993
46. Daniel D, Gill RG, Schloot N, Wegmann D: Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 25:1056-1062, 1995
47. Christianson SW, Shultz LD, Leiter EH: Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice: relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-thy-la donors. Diabetes 42:44-55, 1993
48. Koike T, Itoh Y, Ishii T, Ito I, Takabayashi K, Maruyama N, Tomiokah H, Yoshida S: Preventive effect of mono-clonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 36:539-541, 1987
49. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357, 1986
50. Romagnani S: Human TH1 and TH2 subsets: doubt no more. Immunol Today 12:256-257, 1991
51. Scott P: Selective differentiation of CD4+ T-helper cell subsets. Curr Opin Immunol 5:391-397, 1993
52. Harrison LC, Honeyman MC, De Aizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS: Inverse relation between humoral and cellular immunity to glutamic add decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341:1365-1369, 1993
53. Ellis TM, Darrow B, Campbell L, Atkinson MA: Inverse relationship between humoral and cellular immune responses to glutamate decarboxylase 65 (GAD) and insulin in IDD (Abstract). Diabetes 44 (Suppl. 1):52A, 1995
54. Rabinovitch A: Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 43:613-621, 1994
55. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulin's in non-obese diabetic mice. Nature 366:72-75, 1993
56. Katz JD, Benoist C, Mathis D: T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188, 1995
57. Healey D, Ozegbe P, Arden SD, Chandler P, Button JC, Cooke A: In vivo activity and in vivo specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest 95:2979-2985, 1995
58. Shehadeh NN, LaRosa F, Lafferty KJ: Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 6:291-300, 1993
59. Rothe H, Faust A, Schade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H: Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 37:1154-1158, 1994
60. Campbell IL, Kay TW, Oxbrow L, Harrison LC: Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87:739-742, 1991
61. Debray-Sachs M, Carnaud C, Boitard C, Cohen H, Gresser I, Bedossa P, Bach JF: Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun 4:237-248, 1991
62. Wegmann DR, Gill RG, Norbury-Glaser M, Schloot N, Daniel D: Analysis of the spontaneous T cell response to insulin in NOD mice. J Autoimmun 7:833-843, 1994
63. Wegmann DR, Norbury-Glaser M, Daniel D: Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol 24:1853-1857, 1994
64. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL: Insulin antibodies in insulin-dependent diabetes before insulin treatment. Science 222:1337-1339, 1983
65. Ito Y, Nieda M, Uchigata Y, Nishimura M, Tokunaga K, Kuwata S, Obata F, Tadokoro K, Hirata Y, Omori Y, Juji T: Recognition of human insulin in the context of HLA-DRB1*0406 products by T-cells of insulin autoimmune syndrome patients and healthy donors. J Immunol 151:5770-5776, 1993
66. Miller GG, Pollack MS, Nell U, Thomas JW: Insulin-specific human T cells. J Immunol 139:3622-3629, 1987
67. Scheinin T, Maenpaa J, Koskimies S, Dean BM, Bottazzo GF, Kontiainen S: Insulin responses and lymphocyte subclasses in children with newly-diagnosed insulin-dependent diabetes. Clin Exp Immunol 71:91-95, 1988
68. Scheinin T, Maenpaa J, Kontiainen S: Immune responses to insulin and lymphocyte subclasses at diagnosis of insulin-dependent diabetes and one year later. Immunobiology 180:431-440, 1990
69. Gregory R, Tattersall RB: Bovine and human NPH insulin as T cell immunogens. Diabetes Res Clin Pract 20:139-146, 1993
70. Kuglin B, Gries FA, Kolb H: Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes 37:130-132, 1988
71. Griffin AC, Zhao W, Wegmann KW, Hickley WF: Experimental autoimmune insulitis: induction by T lymphocytes specific for a peptide of proinsulin. Am J Pathol 147:845-857, 1995
72. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A: Autoantibodies in newly diagnosed diabetic children immunoprecipitate specific human islet cell proteins. Nature 298:167-169, 1982
73. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter Olesen H, DeCamilli PD: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
74. Christgau S, Schierbeck H, Aanstoot HJ, Aagaard L, Begley K, Kofod H, Hejnaes K, Baekkeskov S: Pancreatic beta cells express two autoantigenic forms of glutamic acid decarboxylase, a 65-kDa hydrophilic form and a 64-kDa amphiphilic form which can be both membrane-bound and soluble (published erratum appears in J Biol Chem 266:23516, 1991]. J Biol Chem 266:21257-21264, 1991
75. Hagopian WA, Chelsen BM, Karlsen AE, Larsen F, Moody A, Grubin CE, Rowe R, Petersen J, McEvoy R, Lernmark A: Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 42:631-636, 1993
76. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK: Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J Clin Invest 94:2125-2129, 1994
77. Honeyman MC, Cram DS, Harrison LC: Transcription factor jun-B is target of autoreactive T-cells in IDDM. Diabetes 42:626-630, 1993
78. Pak CY, Cha CY, Rajotte RV, McArthur RG, Yoon JW: Human pancreatic islet cell specific 38 kilodalton autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody. Diabetologin 33:569-572, 1990
79. Pak CY, Eun HM, McArthur RG, Yoon JW: Association of cytomegalo-virus infection with autoimmune type 1 diabetes. Lancet ii:1-4, 1988
80. Ko IY, Ihm SH, Yoon JW: Studies on autoimmunity for initiation of beta-cell destruction. VIII. Pancreatic beta-cell dependent autoantibody to a 38 kilodalton protein precedes the clinical onset of diabetes in BB rats. Diabetologia 34:548-554, 1991
81. Neophytou PI, Roep BO, Arden SD, Muir EI, Duinkerken G, Kallan AA, De Vries RRP, Hutton JC: Subtractive expression cloning of a 38kD autoantigen recognised by T-cells from an insulin dependent diabetic patient. Proc Natl Acad Sci USA 93:2014-2018, 1996
82. Arden SD, Roep BO, Neophytou PI, Usac EF, Duinkerken G, De Vries RRP, Hutton JC: Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T-cells from a newly diagnosed type 1 diabetes patient. J Clin Invest 97:551-561, 1996
83. van Noort JM, Sechel AC, Bajramovic JJ, Ouagmiri ME, Polmann CH, Lassmann H, Ravids R: The small heat-shock protein alphaβ-crystallin as candidate autoantigen in multiple sclerosis. Nature 375:798-801, 1995
84. Brudzynski K, Martinez V, Gupta RS: Secretory granule autoantigen in insulin-dependent diabetes-mellitus is related to 62 kDa heat-shock protein (hsp60). J Autoimmun 5:453-463, 1992
85. Brudzynski K, Martinez V, Gupta RS: Immunocytochemical localization of heat-shock protein-60-related protein in beta-cell secretory granules and its altered distribution in non-obese diabetic mice. Diabetologia 35:316-324, 1992
86. Brudzynski K: Insulitis-caused redistribution of heat shock protein HSP60 inside beta-cells correlates with the induction of hsp60 autoantibodies. Diabetes 42:980-913, 1993
87. de Graeff-Meeder ER, Van der Zee R, Rijkers GT, Schuurman HJ, Kuis W, Bijlsma JW, Zegers BJ, Van Eden W: Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 337:1368-1372, 1991
88. Res PC, Schaar CG, Breedveld FC, Van Eden W, Van Embden JD, Cohen IR, De Vries RRP: Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet ii:478-480, 1988
89. Elias D, Reshef T, Birk OS, Van der Zee R, Walker MD, Cohen IR: Vaccination against autoimmune mouse diabetes in young NOD mice with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci USA 88:3088-3091, 1991
90. Elias D, Cohen IR: Peptide therapy for diabetes in NOD mice. Lancet 343:704-700, 1994
91. Elias D, Cohen IR: Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes 44:1132-1138, 1995
92. Pietropaolo M, Castano L, Babu S, Buelow R, Kuo YL, Martin S, Martin A, Powers AC, Prochazka M, Naggert J, Eisenbarth GS: Islet cell autoantigen 69 kD (ICA69): molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 92:359-371, 1993
93. Martin S, Kardorf J, Schulte B, Lampeter EF, Gries FA, Melchers I, Wagner R, Bertrams J, Roep BO, Pfutzner A, Pietropaolo M, Kolb H: Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis. Diabetologia 38:351-355, 1995
94. Roep BO, Duinkerken G, Schreuder GMT, Kolb H, De Vries RRP, Martin S: HLA-associated inverse correlation between T-cell and antibody responsiveness to islet autoantigen in recent-onset insulin dependent diabetes mellitus. Eur J Immunol 26:1285-1289, 1996
95. Miyazaki I, Cheung RK, Gaedigk R, Hui MF, Vandermeulen J, Rajotte RV, Dosch HM: T cell activation and anergy to islet cell antigen in type I diabetes. J Immunol 154:1461-1469, 1995
96. Van Vliet E, Roep BO, Meulenbroek L, Bruining GJ, De Vries RRP: Human T cell clones with specificity for insulinoma cell antigens. Eur J Immunol 19:213-216, 1989
97. Brooks-Worrell B, Palmer J: Investigations into the full spectrum of lymphocyte reactivity in IDDM patients: numerous stimulatory proteins result (Abstract). Diabetes 44 (Suppl. 1):52A, 1995
98. Andersen HU, Larsen PM, Fey SJ, Karlsen AE, Mandrup-Poulsen T, Nerup J: Two-dimensional gel electrophoresis of rat islet proteins: interleukin 1β-induced changes in protein expression are reduced by 1-argenin depletion and nicotinamide. Diabetes 44:400-407, 1995
99. Payton MA, Hawkes CJ, Christie MR: Relationship of the 37,000- and 40,000-m(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule ia-2 (ica512). J Clin Invest 96:1506-1511, 1995
100. Myers MA, Rabin DU, Rowley MJ: Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 44:1290-1295, 1995
101. Castano L, Russo E, Zhou L, Lipes MA, Eisenbarth GS: Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type-I diabetes. J Clin Endocrinol Metab 73:1197-1201, 1991
102. Hutton JC: The insulin secretory granule (Review). Diabetalogia 32:271-281, 1989
103. Bergman B, Haskins K: Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes 43:197-203, 1994
104. Boitard C, Villa MC, Becourt C, Gia HP, Hue C, Sempe P, Portier MM, Bach JF: Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class-II gene products. Proc Natl Acad Sci USA 89:172-176, 1992
105. Haskins K, McDuffie M: Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249:1433-1436, 1990
106. Haskins K, Portas M, Bradley B, Wegmann D, Lafferty K: T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37:1444-1448, 1988
107. Bieg S, Bailyes EM, Yassin N, Amann J, Herberg L, McGregor AM, Scherbaum WA, Banga JP: A multiplicity of protein antigens in subcellular fractions of rat insulinoma tissue are able to stimulate T-cells obtained from non-obese diabetic mice. Diabetologia 36:385-390, 1993
108. Gelber C, Paborsky L, Singer S, Mcateer D, Tisch R, Jolicoeur C, Buelow R, McDevitt, H, Fathman CG: Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes. Diabetes 43:33-39, 1994
109. Wegmann DR, Shehadeh N, Lafferty KJ, Norbury-Glaser M, Gill RG, Daniel D: Establishment of islet-specific T-cell lines and clones from islet isografts placed in spontaneously diabetic NOD mice. J Autoimmun 6:517-527, 1993
110. Kaufman DL, Clare-Salzler MJ, Tian JD, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69-72, 1993
111. Atkinson MA, Maclaren NK, Luchetta R: Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39:933-937, 1990
112. Maclaren N, Lafferty K: The 12th international immunology and diabetes workshop. Diabetes 42:1099-1104, 1993
113. Schloot N, Eisenbarth GS: Isohormonal therapy of endocrine autoimnumity. Immunol Today 16:289-294, 1995
114. Zhang J, Davidson L, Eisenbarth GS, Weiner H: Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 88:10252-10256, 1991
115. Gerling IC, Atkinson MA, Peck AB, Cornelius JG, Leiter EH: Acceleration of IDDM by intrathymic (IT) injection of a glutamic acid decarboxylase (GAD) derived peptide. Diabetes 43 (Suppl. 1):93A, 1994
116. Petersen JS, Karlsen AE, Markholst H, Worsaae A, Dyrberg T, Michelsen B: Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes 43:1478-1484, 1994
117. Sadelain MW, Qin HY, Lauzon J, Singh B: Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39:585-589, 1990
118. Reich EP, Scaringe D, Yagi J, Sherwin RS, Janeway CA Jr: Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes 38:1647-1651, 1989
119. Roep BO, Heidenthal E, De Vries RRP, Kolb H, Martin S: Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus. Lauert 343:1590-1593, 1994
120. Bingley P.J, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EAM: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304-1310, 1994
121. Genovese S, Bingley PJ, Bonifacio E, Christie MR, Shattock M, Bonfanti R, Foxon R, Gale EAM, Bottazzo GF: Combined analysis of IDDM-related autoantibodies in healthy schoolchildren. Lancet 344:756, 1994
122. Kim J, Namchuk M, Bugawan T, Fu Q, Jaffe M, Shi Y, Aanstoot HJ, Turck CW, Erlich H, Lennon V, Baekkeskov S: Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med 180:595-606, 1994
123. Kolb H, Kolb-Bachofen V, Roep BO: Autoimmune versus inflammatory type 1 diabetes: a controversy? Immunol Today 16:170-172, 1995